The President of the Pharmaceutical Society of Nigeria (PSN) led members of the National Executive Committee on a high-level strategic engagement visit to Shalina Healthcare, reinforcing industry collaboration, medicine affordability, and professional excellence.
On Wednesday, 10th February 2026, the President of the Pharmaceutical Society of Nigeria (PSN) led members of the National Executive Committee (NEC) on a strategic engagement visit to Shalina Healthcare. The visit underscored the Society’s commitment to strengthening collaboration between the professional body and key industry stakeholders in advancing Nigeria’s pharmaceutical sector.
Strengthening Access and Affordability
During the engagement, the PSN President acknowledged Shalina Healthcare for filling a significant gap within Nigeria’s pharmaceutical landscape, particularly in advancing the affordability and accessibility of quality medicines for Nigerians. He noted that sustainable access to essential medicines remains central to national health priorities.
He made special reference to the company’s impactful role during the COVID-19 pandemic, observing that its efforts contributed meaningfully to maintaining the supply of essential medicines at a critical time. According to him, such responsiveness reflects corporate responsibility aligned with national healthcare needs.
Ibucap Endorsement: A Strategic Partnership
The President also lauded the successful product endorsement collaboration on Ibucap, which ran from 2024 to 2026. He described the partnership as mutually beneficial and professionally strategic, noting that it exemplifies how structured collaboration between PSN and reputable pharmaceutical companies can promote responsible medicine use while strengthening institutional relationships.
The endorsement collaboration was described as a model of professional synergy that delivered value to both the profession and the public.
He expressed optimism that the endorsement would be renewed and further strengthened in the near future, reinforcing the shared commitment to quality healthcare delivery.
Investing in Young Professionals
Beyond product partnerships, the PSN President commended Shalina Healthcare for promoting excellence within the profession through initiatives such as the SYTA and Rising Stars competitions. He described these platforms as commendable investments in the future of pharmacy practice.
According to him, initiatives that identify, nurture, and empower young talents are critical to sustaining innovation, leadership development, and professional growth within Nigeria’s pharmaceutical ecosystem.
Commitment to Sustained Collaboration
In her remarks, Mrs. Akinyele, Managing Director of Shalina Healthcare, expressed sincere appreciation to the PSN President and the NEC delegation for the visit. She thanked the President for his institutional support and for putting his weight behind Shalina’s products and professional initiatives.
She reaffirmed the company’s commitment to sustaining its collaboration with PSN in advancing quality healthcare delivery, professional development, and improved access to medicines across Nigeria.
The visit further reinforces the strong and strategic relationship between PSN and industry stakeholders in advancing Nigeria’s pharmaceutical sector through collaboration, innovation, affordability, and excellence.
Social Plugin